[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.197.185.157. Please contact the publisher to request reinstatement.
Sign In
Individual Sign In
Create an Account
Institutional Sign In
OpenAthens Shibboleth
[Skip to Content Landing]

January 2017 - July 1959

Decade

Year

Issue

September 1, 2012, Vol 69, No. 9, Pages 872-981

This Month in Archives of General Psychiatry

This Month in Archives of General Psychiatry

Abstract Full Text
free access
Arch Gen Psychiatry. 2012;69(9):873-873. doi:10.1001/archgenpsychiatry.2011.1224
Art and Images in Psychiatry

Albrecht Dürer's Melencolia I

Abstract Full Text
Arch Gen Psychiatry. 2012;69(9):874-874. doi:10.1001/archgenpsychiatry.2012.108
Original Article

Delayed White Matter Growth Trajectory in Young Nonpsychotic Siblings of Patients With Childhood-Onset Schizophrenia

Abstract Full Text
free access
Arch Gen Psychiatry. 2012;69(9):875-884. doi:10.1001/archgenpsychiatry.2011.2084

Gogtay and coauthors evaluated white matter growth differences in 49 healthy siblings of patients with childhood-onset schizophrenia (COS) in a 5-year longitudinal study.

Influence of ZNF804a on Brain Structure Volumes and Symptom Severity in Individuals With Schizophrenia

Abstract Full Text
free access
Arch Gen Psychiatry. 2012;69(9):885-892. doi:10.1001/archgenpsychiatry.2011.2116

Wassink and coworkers performed a case-control analysis of covariance in a volunteer sample of 335 individuals with schizophrenia spectrum disorders and 198 healthy volunteers to evaluate associations of the SNP rs1344706 with brain structure and the core symptoms of schizophrenia.

Failure of Neural Responses to Safety Cues in Schizophrenia

Abstract Full Text
free access
Arch Gen Psychiatry. 2012;69(9):893-903. doi:10.1001/archgenpsychiatry.2011.2310

Holt and colleagues conducted a cross-sectional case control, functional magnetic resonance imaging study to measure autonomic and neural responses during the acquisition and extinction of conditioned fear and the delayed recall of fear and extinction memories in schizophrenic patients and healthy control participants.

Association Between Common Variants Near the Melanocortin 4 Receptor Gene and Severe Antipsychotic Drug–Induced Weight Gain

Abstract Full Text
free access
Arch Gen Psychiatry. 2012;69(9):904-912. doi:10.1001/archgenpsychiatry.2012.191

In a pharmacogenetic association study, Malhotra and coauthors identify single-nucleotide polymorphisms associated with antipsychotic drug–induced weight gain.

Toward Clinically Useful Neuroimaging in Depression TreatmentPrognostic Utility of Subgenual Cingulate Activity for Determining Depression Outcome in Cognitive Therapy Across Studies, Scanners, and Patient Characteristics

Abstract Full Text
free access
Arch Gen Psychiatry. 2012;69(9):913-924. doi:10.1001/archgenpsychiatry.2012.65

Using 2 inception cohorts of depressed and healthy participants, Siegle and coauthors examined whether subgenual anterior cingulate cortex (sgACC) activity serves as a prognostic outcome marker of cognitive therapy for depression and whether sgACC activity changes in treatment.

Reduced Structural Connectivity of a Major Frontolimbic Pathway in Generalized Anxiety Disorder

Abstract Full Text
free access has multimedia
Arch Gen Psychiatry. 2012;69(9):925-934. doi:10.1001/archgenpsychiatry.2011.2178

Tromp et al investigated structural connectivity between ventral prefrontal cortex or anterior cingulate cortex areas and the amygdala in GAD and assessed associations with functional connectivity between those areas. Fractional anisotropy values in the uncinate fasciculus were measured by tract-based analysis for diffusion-tensor imaging data.

National Prevalence of Posttraumatic Stress Disorder Among Sexually Revictimized Adolescent, College, and Adult Household-Residing Women

Abstract Full Text
free access
Arch Gen Psychiatry. 2012;69(9):935-942. doi:10.1001/archgenpsychiatry.2012.132

Using national epidemiologic data from adolescent, college, and household-residing women, Walsh et al estimate the prevalence of sexual revictimization and posttraumatic stress disorder in 3 different populations.

Mania With and Without Depression in a Community Sample of US Adolescents

Abstract Full Text
free access
Arch Gen Psychiatry. 2012;69(9):943-951. doi:10.1001/archgenpsychiatry.2012.38

In a cross-sectional survey, Merikangas et al present the prevalence and clinical correlates of mania with and without depressive episodes in a representative sample of US adolescents.

Common and Unique Therapeutic Mechanisms of Stimulant and Nonstimulant Treatments for Attention-Deficit/Hyperactivity Disorder

Abstract Full Text
free access
Arch Gen Psychiatry. 2012;69(9):952-961. doi:10.1001/archgenpsychiatry.2011.2053

To contrast changes in brain activation related to symptomatic improvement with use of the stimulant methylphenidate vs the nonstimulant atomoxetine, Schulz and coauthors recruited 36 youth with attention-deficit/hyperactivity disorder who underwent functional magnetic resonance imaging from randomized clinical trials.

The Antisocial Brain: Psychopathy MattersA Structural MRI Investigation of Antisocial Male Violent Offenders

Abstract Full Text
free access
Arch Gen Psychiatry. 2012;69(9):962-972. doi:10.1001/archgenpsychiatry.2012.222

Gregory and colleagues conducted a cross-sectional case-control structural magnetic resonance imaging study of 66 men to identify structural gray matter differences between persistent violent offenders who meet criteria for antisocial personality disorder and the syndrome of psychopathy and those meeting criteria only for ASPD.

Randomized Trial of Long-Acting Sustained-Release Naltrexone Implant vs Oral Naltrexone or Placebo for Preventing Relapse to Opioid Dependence

Abstract Full Text
free access
Arch Gen Psychiatry. 2012;69(9):973-981. doi:10.1001/archgenpsychiatry.2012.1a

Naltrexone is approved for treatment of opioid addition in Russia. Krupitsky et al compared rates of relapse among 3 groups of opioid-addicted patients receiving oral naltrexone, implanted naltrexone, or placebo.

×